Digital Health Drug Development healthcare technology 
Digital Health Global
JANUARY 4, 2024
Koneksa’s innovative digital model aims to address limitations in existing functional status assessments by leveraging digital health technologies (DHTs) for both objective and self-reported outcomes. Chief Medical Officer, Koneksa. Chief Scientific Officer, Koneksa.
Digital Health Global
APRIL 25, 2024
This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., The study, led by principal investigator Nitin Ohri, M.D., Chief Medical Officer, Koneksa. “By
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
MARCH 2, 2023
Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.
Lloyd Price
JULY 15, 2024
Exec Summary: Digital Health is a subset of Healthtech. Digital Health focuses on the individual patient, while Healthtech focuses on the entire healthcare ecosystem. Artificial intelligence: This is a rapidly developing field that has the potential to revolutionize healthcare. Subscribe Today!
Digital Health Global
JUNE 13, 2023
“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.
Lloyd Price
NOVEMBER 16, 2024
With significant investments and a focus on innovation, Merative is poised to play a major role in shaping the future of healthcare data analytics and technology. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Subscribe Today!
Lloyd Price
DECEMBER 2, 2024
The increasing importance of digital health, coupled with abundant capital and supportive regulatory environments, is likely to drive continued M&A activity and higher valuations. Regulatory Environment: Favourable regulatory policies and increased government support for digital health initiatives are fostering innovation.
Expert insights. Personalized for you.
88 
Let's personalize your content